I have been told I am to be discussed at MDT, what does this mean?
Don’t panic! Most patients with complex conditions like aspergillosis will hear the term ‘MDT’ at some point in their journey to diagnosis or afterwards.
But what does it mean?
MDT stands for Multidisciplinary Team and is often associated with the care of patients with cancer or suspected cancer; however, MDTs are also used to inform the decision-making process in the care of patients with other conditions, particularly those that are complex.
Okay, so who is in this team, and what do they do?
This team is far more impressive than any sporting team out there. A Multidisciplinary Team brings together a range of clinicians and specialists, all of whom bring their professional expertise in diagnosis, treatment options, and individual patients’ overall care – ensuring a joint approach to care.
In the context of the aspergillosis MDT, the team meet once a week, and the core members are:
- Doctors
- Nurses
- Physiotherapists
- Pharmacists
- Laboratory staff
One of the doctors or nurses in attendance will always be the referring clinician. This ensures a patient-centred approach as there is an advocate for the patient who knows their personal circumstances and wishes.
What do they discuss?
This is dependent on the individual case. The team will review (and where possible compare) CT scans, X-rays, laboratory results and medications. They will discuss referral letters, look at the patient history and take into account discussions with the patient.
Does this delay my treatment or diagnosis?
In short, no.
Being told you need to be discussed at MDT may feel like it is delaying treatment or answers; however, MDTs are held weekly and are an essential element in managing complex conditions to ensure the best possible care and treatment in line with national guidance and best practice.
Will I get to know the outcome?
Yes, the team’s conclusions and recommendations will be fed back to you at your next appointment, or earlier if necessary, for example, if you need to change medication or have more tests.
When will I be discussed at MDT?
Patients can be referred to the MDT at any point in their journey, be it while a diagnosis of aspergillosis is being considered, or if changes occur and alternative treatment options need to be discussed.
You can find more detailed information produced by the NHS on MDTs here.
If you want to access additional support materials about aspergillosis, click here.
Share this post
Latest News posts
Patients & Carers meeting July 2015
January 11, 2019
Patients & Carers meeting June 2015
January 10, 2019
Patients & Carers meeting May 2015
January 10, 2019
Patients & Carers meeting March 2015
January 10, 2019
Patients & Carers meeting February 2015
January 10, 2019
Patients & Carers meeting December 2014
January 10, 2019
Patients & Carers meeting November 2014
January 10, 2019
Patients & Carers meeting October 2014
January 10, 2019
Patients & Carers meeting September 2014
January 10, 2019
Patients & Carers meeting January 2014
January 10, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video